Skip to main content
logo
Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.090
+0.020 (1.87%)
Jul 3, 2026, 5:29 PM CET

Diamyd Medical AB Revenue

Diamyd Medical AB had revenue of 70.00K SEK in the quarter ending May 31, 2026. This brings the company's revenue in the last twelve months to 432.00K, up 234.88% year-over-year. In the fiscal year ending August 31, 2025, Diamyd Medical AB had annual revenue of 130.00K.

Revenue (ttm)
432.00K
Revenue Growth
+234.88%
P/S Ratio
391.05
Revenue / Employee
9.82K
Employees
44
Market Cap
168.93M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Aug 31, 2025130.00K--
Aug 31, 2024130.00K-416.00K-76.19%
Aug 31, 2023546.00K92.00K20.26%
Aug 31, 2022454.00K201.00K79.45%
Aug 31, 2021253.00K-88.00K-25.81%
Aug 31, 2020 Pro Pro Pro
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
IRLAB Therapeutics AB92.46M
Xbrane Biopharma AB76.45M
Nanologica AB31.83M
Elicera Therapeutics AB10.64M
NextCell Pharma AB9.24M
Xintela AB2.59M
Simris Group AB (PUBL)1.88M
Alligator Bioscience AB520.00K
Revenue Rankings

Diamyd Medical AB News

More News